Transplantation

Liver Transplantation

Latest AI and machine learning research in liver transplantation for healthcare professionals.

3,703 articles
Stay Ahead - Weekly Liver Transplantation research updates
Subscribe
Browse Categories
Showing 261-280 of 3,703 articles

Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial.

BACKGROUND & AIMS: Resmetirom, a thyroid hormone beta (THR-β) agonist, has been shown to improve metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis in patients with non-cirrhotic MASH in a phase III serial liver biopsy study. In the phase III MAESTRO-NASH trial, the impact of resmetirom compared with placebo on histologic fibrosis features was evaluated using artificial intellige...

Mar 25 2026 41895606

Path forward: Cryoablation for colorectal liver metastases.

PURPOSE: Colorectal liver metastases (CRLM) are a leading cause of mortality in patients with colorectal cancer. While surgical resection is the standard curative option, most patients are ineligible. Consequently, cryoablation (CA) has emerged as a potential alternative. This review aims to summarise the technical characteristics, clinical outcomes, immunomodulatory effects, and current combinati...

Mar 25 2026 41926877
Clinical prediction of the mortality for acute kidney injury in decompensated cirrhosis.

Acute kidney injury (AKI) is a severe complication in patients with decompensated cirrhosis, associated with increased mortality. This study aimed to ...

Mar 25 2026 41882042
Predicting the Risk of Decompensation in Patients with Cirrhosis - a Validated Machine Learning Approach.

INTRODUCTION: There is an unmet need for simple tools to predict development of hepatic decompensation among patients with compensated cirrhosis. We a...

Mar 25 2026 41879220
Harnessing the gut microbiota in extra-intestinal cancers: from causal evidence to immunotherapy strategies.

The gut microbiota (GM) has emerged as a key modulator of cancer development and therapeutic response beyond the gastrointestinal tract. In extra-inte...

Mar 24 2026 41873461
TCR recognition of peptide-HLA class II complexes in autoimmunity: Structural insights for therapeutic targeting.

Autoimmune diseases encompass a broad spectrum of disorders in which self-reactive T and B cells breach immune tolerance and drive chronic tissue infl...

Mar 23 2026 41875606
Machine learning derived ORC6 as a hub biomarker for predicting tumor microenvironment, prognoses, and therapeutic responses in lung adenocarcinoma.

The origin recognition complex (ORC) is a DNA-binding complex composed of six subunits involved in DNA replication in cancer cells. The prognostic and...

Mar 23 2026 41875810
Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the Liver.

Artificial Intelligence (AI) is transforming medicine, providing unprecedented opportunities to enhance diagnosis, prognosis, and treatment across all...

Mar 23 2026 41876274
Predictive value of Hypotension Prediction Index in liver transplantation: a prospective study.

BACKGROUND: Intraoperative hypotension (IOH) is associated with increased postoperative morbidity and mortality. This prospective study evaluated the ...

Mar 23 2026 41870962
Stage-dependent gut microbiome and functional signatures across the liver disease spectrum: an integrative multicohort study.

BACKGROUND: The gut-liver axis plays a critical role in liver disease progression; however, how gut microbial ecology and function vary across disease...

Mar 23 2026 41871945
Precision oncology meets nanotechnology: AI-driven liposomal nanocarriers for enhanced cancer immunotherapy.

The integration of artificial intelligence (AI) with nanotechnology is redefining therapeutic strategies in cancer immunotherapy and chemotherapy. The...

Mar 21 2026 41871725
GCN combined with snake convolution for enhanced topological perception in thrombotic hepatic portal vein segmentation.

The hemodynamic status of the portal vein plays a crucial role in the identification, treatment, and prognostic prediction of complications associated...

Mar 21 2026 41932133
Integrated single-cell and bulk transcriptomics reveals STAB1 as a novel therapeutic target for ovarian cancer.

The immunosuppressive tumor microenvironment (TME) and intrinsic heterogeneity of ovarian cancer (OC) are primary drivers of therapeutic resistance an...

Mar 21 2026 41865597
Development and Validation of a Machine Learning Model for Predicting 3-Year Overall Survival After Transjugular Intrahepatic Portosystemic Shunt: A Retrospective Multicenter Study.

BACKGROUND AND AIMS: Predicting overall survival (OS) in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) remains ch...

Mar 19 2026 41848728
Protocol for a global electronic Delphi on integrating artificial intelligence into solid organ transplantation.

Artificial intelligence (AI) is increasingly recognized as a transformative force in the field of solid organ transplantation. From enhancing donor-re...

Mar 18 2026 41607824
Noninvasive Detection of Occult yet Significant Liver Pathology in Alanine Aminotransferase-Normal Chronic Hepatitis B: A Multicenter Study.

BACKGROUND: Individuals with chronic hepatitis B (CHB) may harbor occult yet significant liver pathology despite normal alanine aminotransferase (ALT)...

Mar 17 2026 41165446
Immune checkpoint molecules beyond PD-1 and CTLA-4: emerging targets in autoimmune diseases and cancer immunotherapy.

BACKGROUND: Immune checkpoint molecules are pivotal regulators of immune activation and tolerance, playing critical roles in cancer, autoimmunity, inf...

Mar 17 2026 41842954
Comprehensive Multiomics Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies.

UNLABELLED: Perineural invasion (PNI) is an important pathologic feature of cervical cancer that is associated with poor prognosis and provides key in...

Mar 16 2026 41379570
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting Parthanatos.

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, primarily due to its low immunogenicity and immunosuppre...

Mar 16 2026 41834604
Browse Categories